Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
Arqit Quantum
ARQQ
$305M
| $22.9K | ﹤0.01% |
2,673
-10,448
| -80% | -$113K |
|
4777
Sky Harbour Group
SKYH
$367M
| $22.8K | ﹤0.01% |
+2,468
| New | +$25.7K |
|
|
IGMS
4778
DELISTED
IGM Biosciences
IGMS
| $22.8K | ﹤0.01% |
3,320
+796
| +32% | +$6.81K |
|
4779
Acumen Pharmaceuticals
ABOS
$165M
| $22.8K | ﹤0.01% |
9,415
-125,979
| -93% | -$401K |
|
4780
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.43B
| $22.7K | ﹤0.01% |
954
+4
| +0.4% | +$95 |
|
4781
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.65B
| $22.6K | ﹤0.01% |
452
+47
| +12% | +$2.35K |
|
4782
First Northwest Bancorp
FNWB
$113M
| $22.5K | ﹤0.01% |
2,323
-12,425
| -84% | -$138K |
|
4783
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$19M
| $22.5K | ﹤0.01% |
50,001
| – | – |
|
4784
Fidus Investment
FDUS
$767M
| $22.5K | ﹤0.01% |
1,154
+388
| +51% | +$7.71K |
|
4785
Neuropace
NPCE
$522M
| $22.4K | ﹤0.01% |
2,969
-72,719
| -96% | -$734K |
|
4786
Greenwich LifeSciences
GLSI
$196M
| $22.4K | ﹤0.01% |
1,299
-6,958
| -84% | -$102K |
|
4787
D-Wave Quantum Inc. Common Stock
QBTS
$6.56B
| $22K | ﹤0.01% |
19,332
-8,816
| -31% | -$12.4K |
|
4788
Sportradar
SRAD
$4.4B
| $22K | ﹤0.01% |
+1,965
| New | +$20.4K |
|
|
WKME
4789
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $21.8K | ﹤0.01% |
1,563
-938
| -38% | -$9.17K |
|
4790
Fidelity MSCI Industrials Index ETF
FIDU
$2.34B
| $21.8K | ﹤0.01% |
334
+17
| +5% | +$1.12K |
|
4791
Stereotaxis
STXS
$127M
| $21.8K | ﹤0.01% |
11,955
-241,037
| -95% | -$541K |
|
4792
FerroAtlántica
GSM
$626M
| $21.7K | ﹤0.01% |
4,057
+1,271
| +46% | +$6.92K |
|
4793
Urban One Class D
UONEK
$22.8M
| $21.6K | ﹤0.01% |
1,442
+1,227
| +571% | +$20.5K |
|
|
VRNA
4794
DELISTED
Verona Pharma
VRNA
| $21.4K | ﹤0.01% |
1,477
+1,230
| +498% | +$18K |
|
4795
XBiotech
XBIT
$69.2M
| $21.4K | ﹤0.01% |
4,154
-32,598
| -89% | -$251K |
|
4796
X4 Pharmaceuticals
XFOR
$366M
| $21.2K | ﹤0.01% |
1,219
-3,016
| -71% | -$98.6K |
|
4797
Intuitive Machines
LUNR
$1.97B
| $21.1K | ﹤0.01% |
6,381
-58,746
| -90% | -$292K |
|
|
TSE
4798
DELISTED
Trinseo
TSE
| $21K | ﹤0.01% |
9,111
+2,329
| +34% | +$7.25K |
|
4799
Finance of America Companies
FOA
$219M
| $21K | ﹤0.01% |
4,256
+2,499
| +142% | +$15.2K |
|
4800
Alto Neuroscience
ANRO
$1.06B
| $20.9K | ﹤0.01% |
1,953
-31,889
| -94% | -$415K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.